Aceon vs. Catapres-tts-1: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Aceon and Catapres-tts-1. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 93,724 people who take Aceon and Catapres-tts-1, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
93,724 people who take Aceon and Catapres-tts-1 are studied.
What is Aceon?
Aceon has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 1,783 Aceon users for its effectiveness, alternative drugs and more.
What is Catapres-tts-1?
Catapres-tts-1 has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 2,047 Catapres-tts-1 users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Aceon (perindopril erbumine)
- Catapres-Tts-1 (clonidine)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Aceon:
- not at all: 2.14 %
- somewhat: 12.6 %
- moderate: 35.12 %
- high: 39.68 %
- very high: 10.46 %
Catapres-Tts-1:
- not at all: 3.9699999999999998 %
- somewhat: 20.38 %
- moderate: 33.85 %
- high: 31.67 %
- very high: 10.13 %
Want to compare Aceon with Catapres-tts-1?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Aceon (1,743 reports)
- Catapres-tts-1 (1,988 reports)
Common Aceon side effects:
- Angioedema (rapid swelling of the dermis): 134 reports
- Breathing difficulty: 120 reports
- High blood pressure: 121 reports
- Hypotension (abnormally low blood pressure): 104 reports
- Nausea (feeling of having an urge to vomit): 116 reports
- Weakness: 123 reports
Common Catapres-tts-1 side effects:
- Application site erythema (redness of the skin at application site): 238 reports
- Application site irritation: 110 reports
- Application site pruritus (application site severe itching of the skin): 247 reports
- Application site rash: 168 reports
- Blood pressure management: 160 reports
- Dizziness: 118 reports
- Drug ineffective: 186 reports
- Headache (pain in head): 150 reports
- High blood pressure: 486 reports
- Rashes (redness): 119 reports
How the study uses the data?
The study is based on perindopril erbumine and clonidine (the active ingredients of Aceon and Catapres-tts-1, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cymbalta and Paraesthesia Oral - 6 seconds ago
- Vioxx and Hypercapnia - 7 seconds ago
- Fosamax and Dexchlorpheniramine Maleate drug interaction - 15 seconds ago
- Spiriva and Burning Sensation - 21 seconds ago
- Celecoxib and Hydrocodone drug interaction - 22 seconds ago
- Seroquel and Hypoacusis - 30 seconds ago
- Zide and Rib Fracture - 58 seconds ago
- Amlodipine Besylate and Investigation Abnormal - a minute ago
- Nipride and Lovenox drug interaction - a minute ago
- Valium and Body Height Decreased - a minute ago